Enhancing self-management and patient empowerment reduces healthcare utilization without compromising health outcomes
Gastrointestinal protection (BPC-157): Cytoprotective and ulcer-healing effects across the GI tract are the peptides original and best-characterised preclinical focus [1]
Although the impact of such feed-forward connections is currently unknown, we postulate that these speculative multi-phasic responses in thalamus evoked by cerebellar nuclei stimulation aid to stop thalamo-cortical oscillations by increasing the excitatory drive onto thalamic relay neurons and by desynchronizing thalamo-cortical activity
Thereby, with the beneficial effect in rats with either inferior caval vein occlusion (Vukojevic et al., 2018) or bilateral carotid artery occlusion, there is increased Egr1 expression, which is relevant for both, but especially so in the ischemia/reperfusion stroke rats
Theyre on the face, chest and back
In clinical practice, the addition of BPC-157 has been associated with improved rather than worsened GI tolerance, consistent with BPC-157's known gastroprotective pharmacology
